- Home
- VIRC vs TLSI Comparison
VIRC vs TLSI Comparison
Compare VIRC & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRC
- TLSI
- Stock Information
- Founded
- VIRC 1950
- TLSI 2010
- Country
- VIRC United States
- TLSI United States
- Employees
- VIRC N/A
- TLSI N/A
- Industry
- VIRC Industrial Specialties
- TLSI Medical Specialities
- Sector
- VIRC Consumer Discretionary
- TLSI Health Care
- Exchange
- VIRC Nasdaq
- TLSI Nasdaq
- Market Cap
- VIRC 158.2M
- TLSI 160.4M
- IPO Year
- VIRC N/A
- TLSI N/A
- Fundamental
- Price
- VIRC $8.77
- TLSI $5.02
- Analyst Decision
- VIRC Buy
- TLSI Strong Buy
- Analyst Count
- VIRC 1
- TLSI 6
- Target Price
- VIRC $19.00
- TLSI $11.75
- AVG Volume (30 Days)
- VIRC 100.9K
- TLSI 33.4K
- Earning Date
- VIRC 06-06-2025
- TLSI 05-14-2025
- Dividend Yield
- VIRC 1.16%
- TLSI N/A
- EPS Growth
- VIRC N/A
- TLSI N/A
- EPS
- VIRC 1.32
- TLSI N/A
- Revenue
- VIRC $266,240,000.00
- TLSI $29,431,000.00
- Revenue This Year
- VIRC $3.63
- TLSI $56.00
- Revenue Next Year
- VIRC $2.60
- TLSI $52.17
- P/E Ratio
- VIRC $6.53
- TLSI N/A
- Revenue Growth
- VIRC N/A
- TLSI 58.99
- 52 Week Low
- VIRC $8.13
- TLSI $3.50
- 52 Week High
- VIRC $18.50
- TLSI $10.24
- Technical
- Relative Strength Index (RSI)
- VIRC 41.49
- TLSI 34.87
- Support Level
- VIRC $8.13
- TLSI $4.66
- Resistance Level
- VIRC $8.99
- TLSI $5.40
- Average True Range (ATR)
- VIRC 0.36
- TLSI 0.37
- MACD
- VIRC -0.06
- TLSI -0.06
- Stochastic Oscillator
- VIRC 34.59
- TLSI 29.51
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.